Peptides for Recovery & Tissue Repair

Home/Collections/Peptides for Recovery & Tissue Repair

Research-Grade Peptides

Recovery & Tissue Repair

Peptides for Recovery & Tissue Repair

Peptides for recovery and repair are compounds studied for how tissue regenerates — across tendons, ligaments, muscle, connective tissue and the gastrointestinal lining. This is the deepest category in the Purist range, and the compounds within it are frequently studied in combination because they act on complementary stages of the repair process.

99%+ Verified Purity
Independent HPLC Assay
Third-Party Lab Tested
Lyophilised & Sealed

View the 8 compounds How to choose

Purist Peptides research vials for recovery and repair research

8Compounds in category

99%+Minimum verified purity

HPLCIndependent assay method

2Published COAs in category

99%+ PurityThird-Party Lab TestedCOA AvailableSecure Packaging

GLOW

R 1,799

Tesamorelin

R 2,800

Purist Peptides CJC-1295 with DAC vial - growth hormone, muscle growth and recovery research peptide

CJC-1295 w DAC

R 1,200

KLOW

R 2,750

GHK-CU

R 650

TB-500

R 1,300

BPC-157 + TB-500 - WOLVERINE STACK

R 1,600

BPC-157

R 500

Mechanisms

How tissue repair is studied

Regeneration research separates into distinct mechanisms: cellular migration to the injury site, angiogenesis (new blood-vessel formation supplying the repair), fibroblast activity and collagen synthesis rebuilding the matrix, and cytoprotective and anti-inflammatory signalling limiting secondary damage. BPC-157 is most referenced for localised tendon, ligament and gut-lining repair; TB-500 for cellular migration and systemic connective-tissue recovery. Because they address different stages, they are the most commonly paired peptides in regenerative research.

Purist Peptides research compounds in a laboratory setting

Study design

Localised versus systemic repair

Protocols differ by target. Localised models often administer near the affected area, while systemic models use subcutaneous dosing and longer cycles. Typical research cycles run 4–8 weeks and extend to 12 for post-surgical models, followed by a lower-dose maintenance phase. Load management, rest and structured rehabilitation remain part of any credible recovery model — the compounds are studied alongside them, not instead of them.

The range

Compounds in this category

The compounds grouped here, each with the pathway it is studied for and the protocol shape most often used.

BPC-157

Localised tissue repair

A synthetic peptide studied for tendon, ligament, muscle and gastrointestinal-lining repair, with documented cytoprotective and anti-inflammatory signalling. Published third-party test report available.

Researched at 250–750 mcg, 1–2× daily over 4–8 weeks

View BPC-157

TB-500

Systemic mobility & fascia

Studied for cellular migration, angiogenesis and connective-tissue recovery, including fascial health and range of motion. Published test report available.

Typically 1–2 mg, 2–3× weekly over 4–8 weeks

View TB-500

BPC-157 + TB-500 (Wolverine)

Dual-stage repair

Both compounds in a single vial for coordinated local and systemic repair research; the most-requested pairing in regenerative protocols.

View BPC-157 + TB-500 (Wolverine)

KLOW

Multi-peptide + KPV

A four-peptide complex (GHK-Cu, BPC-157, TB-500, KPV) adding a KPV anti-inflammatory component for advanced regenerative models.

View KLOW

GLOW

Multi-peptide blend

A GHK-Cu, TB-500 and BPC-157 blend studied for skin and systemic repair; the lighter alternative to KLOW.

View GLOW

GHK-Cu

Copper tripeptide

A copper-binding peptide studied for collagen synthesis, extracellular-matrix renewal and wound healing. Notably, it does not require cycling. Published test report available.

View GHK-Cu

CJC-1295 w DAC

Long-acting GHRH

A GHRH analogue contributing sustained growth-hormone and IGF-1 signalling to recovery models.

View CJC-1295 w DAC

Tesamorelin

GHRH analogue

A GHRH analogue referenced for growth-hormone-driven systemic repair and sleep-phase recovery.

View Tesamorelin

Selection

How to choose

Start from the research question, not the compound name.

If the research question is…	Start with
Acute injury, tendon or ligament	BPC-157, or the Wolverine combination for both repair stages
Systemic recovery, mobility and fascia	TB-500
Gut-lining and mucosal models	BPC-157
Structural collagen and matrix	GHK-Cu
Full multi-peptide protocol	KLOW (with KPV) or GLOW (lighter)

Pre-paired

Stacks built on this category

Complete research cycles — every vial needed for the full protocol, 10% below buying the vials separately.

Recovery StackWolverine + Tesamorelin — complete 8-week cycle, 3 vials.View the stack Performance Recovery StackWolverine + CJC-1295 w DAC — complete 8-week cycle, 3 vials.View the stack

Independent laboratory testing of Purist Peptides research compounds

Verified quality

Tested before it ships

Published third-party test reports for BPC-157, TB-500 and GHK-Cu · minimum 99% verified purity · every product page carries full reconstitution volumes, dose-conversion tables and cycle guidance · lyophilised, refrigerate 2–8 °C after reconstitution. See Quality Standards.

BPC-15799.98% · COA PDF BPC-157 + TB-500100%+ · COA PDF

See Quality Standards & all COAs

Questions

Recovery research FAQ

What is the difference between BPC-157 and TB-500?

BPC-157 is most referenced for localised repair — tendon, ligament and gastrointestinal lining — with cytoprotective signalling. TB-500 is studied for cellular migration, angiogenesis and systemic connective-tissue recovery. They address different stages of repair, which is why the Wolverine combination pairs both.

Can recovery peptides be studied together?

Yes — this is the most commonly combined category in the range, because the compounds act on complementary repair mechanisms rather than duplicating one. KLOW and GLOW are pre-formulated multi-peptide blends built on that principle.

Does GHK-Cu need to be cycled?

No. GHK-Cu occurs naturally in human plasma and does not cause receptor down-regulation, so research protocols commonly run continuously for 3–6 months rather than in on/off cycles. Daily exposure above 3 mg is not advised due to copper accumulation.

How long is a typical recovery research cycle?

Most protocols run 4–8 weeks, extending to 12 weeks for post-surgical or intensive models, followed by a reduced maintenance dose 2–5× weekly. Specific protocols are documented on each product page.

Do these replace rest and rehabilitation?

No. Recovery research treats the compound as one input; load management, rest and structured rehabilitation remain central to the model and are held constant in well-designed studies.

Keep exploring

Related research categories

Skin & Collagen Lean Muscle & Growth Anti-Ageing & Longevity Sleep & Mood The full range All peptide stacks

Research-grade, verified, traceable.

Every batch assayed by an independent laboratory before release — minimum 99% verified purity.

Shop this category Quality Standards

Research use only. Not for human or veterinary consumption. Supplied strictly for qualified researchers and laboratory settings.

Browse all research peptides → View Quality Standards

Peptides for Recovery & Tissue Repair

Filters

GLOW

Tesamorelin

CJC-1295 w DAC

KLOW

GHK-CU

TB-500

BPC-157 + TB-500 - WOLVERINE STACK

BPC-157

How tissue repair is studied

Localised versus systemic repair

Compounds in this category

BPC-157

TB-500

BPC-157 + TB-500 (Wolverine)

KLOW

GLOW

GHK-Cu

CJC-1295 w DAC

Tesamorelin

How to choose

Stacks built on this category

Tested before it ships

Recovery research FAQ

What is the difference between BPC-157 and TB-500?

Can recovery peptides be studied together?

Does GHK-Cu need to be cycled?

How long is a typical recovery research cycle?

Do these replace rest and rehabilitation?

Related research categories

Research-grade, verified, traceable.

Popular Searches

Cart (0)

Search

Recently Viewed